We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine

Culture-negative endocarditis caused by Stenotrophomonas maltophilia: a report of two cases

    Rayvathy Balasubramanian

    Department of Microbiology, Dr. ALM PG Institute of Basic Medical Sciences, University of Madras, Taramani, Chennai, 600113, India

    ,
    Pierre-Edouard Fournier

    UMR VITROME, Aix-Marseille University, Institut Hospitalo-Universitaire Méditerranée Infection, Marseille, 13005, France

    &
    Thangam Menon

    *Author for correspondence: Tel.: +91 877 816 5117;

    E-mail Address: thangam56@gmail.com

    Department of Microbiology, Saveetha Dental College & Hospitals, Chennai, 600077, India

    Published Online:https://doi.org/10.2217/fmb-2021-0313

    Stenotrophomonas maltophilia, an aerobic, non-fermenting, Gram-negative bacterium, is an emerging nosocomial pathogen. It is considered to be a low-grade pathogen, and infections due to S. maltophilia are uncommon. However, in the recent past, S. maltophilia infections have been on the rise, particularly in patients who are either immunocompromised, aged or on long-term antibiotic therapy. Endocarditis due to S. maltophilia is extremely rare. This is a report of two patients with S. maltophilia endocarditis who were diagnosed by 16S rRNA gene sequencing.

    References

    • 1. Brooke JS. Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin. Microbiol. Rev. 25(1), 2–41 (2012).
    • 2. Fenollar F, Roux V, Stein A, Drancourt M, Raoult D. Analysis of 525 samples to determine the usefulness of PCR amplification and sequencing of the 16S rRNA gene for diagnosis of bone and joint infections. J. Clin. Microbiol. 44(3), 1018–1028 (2006).
    • 3. Rothman RE, Majmudar MD, Kelen GD et al. Detection of bacteremia in emergency department patients at risk for infective endocarditis using universal 16S rRNA primers in a decontaminated polymerase chain reaction assay. J. Infect. Dis. 186(11), 1677–1681 (2002).
    • 4. Hugh R, Ryschenkow E. Pseudomonas maltophilia, an alcaligenes-like species. Microbiology 26(1), 123–132 (1961).
    • 5. Swings J, De Vos P, Van den Mooter M, De Ley J. Transfer of Pseudomonas maltophilia Hugh 1981 to the genus Xanthomonas as Xanthomonas maltophilia (Hugh 1981) comb. nov. Int. J. Syst. Bacteriol. 33(2), 409–413 (1983).
    • 6. Palleroni NJ, Bradbury JF. Stenotrophomonas, a new bacterial genus for Xanthomonas maltophilia (Hugh 1980) Swings et al. 1983. Int. J. Syst. Evol. Microbiol. 43(3), 606–609 (1993).
    • 7. Gröschel MI, Meehan CJ, Barilar I et al. The phylogenetic landscape and nosocomial spread of the multidrug-resistant opportunist Stenotrophomonas maltophilia. Nat. Commun. 11(1), 1–2 (2020).
    • 8. Denton M, Todd NJ, Kerr KG, Hawkey PM, Littlewood JM. Molecular epidemiology of Stenotrophomonas maltophilia isolated from clinical specimens from patients with cystic fibrosis and associated environmental samples. J. Clin. Microbiol. 36(7), 1953–1958 (1998).
    • 9. Zhang LI, Xian-Zhi LI, Poole K. Multiple antibiotic resistance in Stenotrophomonas maltophilia: involvement of a multidrug efflux system. Antimicrob. Agents Chemother. 44(2), 287–293 (2000).
    • 10. VanCouwenberghe CJ, Farver TB, Cohen SH. Risk factors associated with isolation of Stenotrophomonas (Xanthomonas) maltophilia in clinical specimens. Infect. Control Hosp. Epidemiol. 18(5), 316–321 (1997).
    • 11. Munter RG, Yinnon AM, Schlesinger Y, Hershko C. Infective endocarditis due to Stenotrophomonas (Xanthomonas) maltophilia. Eur. J. Clin. Microbiol. Infect. Dis. 17(5), 353–356 (1998).
    • 12. Bayle S, Rovery C, Sbragia P, Raoult D, Brouqui P. Stenotrophomonas maltophilia prosthetic valve endocarditis: a case report. J. Med. Case Rep. 2(1), 1–3 (2008).
    • 13. Crum NF, Utz GC, Wallace MR. Stenotrophomonas maltophilia endocarditis. Scand. J. Infect. Dis. 34(12), 925–927 (2002).
    • 14. Subhani S, Patnaik AN, Barik R, Nemani L. Infective endocarditis caused by Stenotrophomonas maltophilia: a report of two cases and review of literature. Indian Heart J. 68(Suppl. 2), S267–S270 (2016).
    • 15. Shah D, Chawla K, Kandpal B. Stenotrophomonas maltophilia – a rare cause of prosthetic valve endocarditis: a case report and review of literature. J. Med. Sci. Clin. Res. 5(7), 25860–25863 (2017).
    • 16. Kogler W, Davison N, Richardson A, Rollini F, Isache C. Endocarditis caused by Stenotrophomonas maltophilia – a rare presentation of an emerging opportunistic pathogen. IDCases 17, e00556 (2019).